W. Arns

发表

Everolimus in patients with autosomal dominant polycystic kidney disease.

Martin Büchert, Kai-Uwe Eckardt, Klemens Budde, 2010, The New England journal of medicine.

Unacceptable human leucocyte antigens for organ offers in the era of organ shortage: influence on waiting time before kidney transplantation

I. König, P. Reinke, D. Stippel, 2017, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Enteric‐Coated Mycophenolate Sodium is Therapeutically Equivalent to Mycophenolate Mofetil in de novo Renal Transplant Patients

Jeff Maca, Federico Oppenheimer, J. Maca, 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Rescue allocation and recipient oriented extended allocation in kidney transplantation—influence of the EUROTRANSPLANT allocation system on recipient selection and graft survival for initially nonaccepted organs

M. Hellmich, A. Kribben, D. Stippel, 2017, Transplant International.

Therapeutic drug monitoring of mycophenolic acid in solid organ transplant patients treated with mycophenolate mofetil: review of the literature.

K. Budde, W. Arns, R. Walker, 2006, Transplantation.

Enteric‐coated mycophenolate sodium delivers bioequivalent MPA exposure compared with mycophenolate mofetil

W. Arns, R. Schmouder, S. Choudhury, 2005, Clinical transplantation.

Laparoscopic live donor nephrectomy: Are ten cases per year enough to reach the quality standards? A report from a single small-volume transplant center

W. Arns, A. Paul, M. Nagelschmidt, 2010, Surgical Endoscopy.

[The way to establish laparoscopic donor nephrectomy as the method of choice in live kidney donation--a single centre experience].

W. Arns, A. Paul, M. Heiss, 2008, Zentralblatt fur Chirurgie.

Laparoscopic live donor nephrectomy for right kidneys: Experience in a German community hospital

W. Arns, A. Paul, M. Heiss, 2008, Surgical Endoscopy.

Mycophenolate mofetil maintenance therapy in renal transplant patients: long‐term results of the TranCept STAY study

K. Budde, W. Arns, H. Haller, 2012, Clinical transplantation.

Secreted frizzled-related protein 4 predicts progression of autosomal dominant polycystic kidney disease.

C. Wanner, B. Banas, K. Budde, 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Bone disease after renal transplantation.

A. Schwarz, R. Wüthrich, U. Kunzendorf, 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Noninvasive Diagnosis of Acute Rejection in Renal Transplant Patients Using Mass Spectrometric Analysis of Urine Samples: A Multicenter Diagnostic Phase III Trial

P. Marquet, K. Budde, W. Arns, 2022, Transplantation direct.

Preformed Donor-Specific HLA Antibodies in Living and Deceased Donor Transplantation: A Multicenter Study.

I. König, A. Rahmel, P. Reinke, 2019, Clinical journal of the American Society of Nephrology : CJASN.

Impact of daclizumab, low-dose cyclosporine, mycophenolate mofetil and steroids on renal function after kidney transplantation.

K. Budde, W. Arns, H. Neumayer, 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials

F. Lehner, P. Reinke, K. Budde, 2018, BMC Nephrology.

HIGH RESPONDER RATE AFTER CALCINEURIN-INHIBITOR WITHDRAWL AND INTRODUCTION OF SIROLIMUS THERAPY IN PATIENTS WITH DETERIORATING RENAL FUNCTION.

W. Arns, M. Zeier, U. Lange, 2006 .

CONVERSION FROM TACROLIMUS TO EVEROLIMUS DOES NOT INFLUENCE THE PHARMACOKINETIC BUT INCREASES PHARMACODYNAMIC RESPONSE OF MYCOPHENOLATE SODIUM IN RENAL TRANSPLANT PATIENTS.

K. Budde, W. Arns, P. Glander, 2006 .

CONVERSION FROM CYCLOSPORINE TO EVEROLIMUS LEADS TO BETTER RENAL FUNCTION AND TO PROFOUND CHANGES IN EVEROLIMUS AND MYCOPHENOLATE METABOLISM

K. Budde, W. Arns, P. Glander, 2006 .

Conversion From Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Maintenance Renal Transplant Recipients Receiving Tacrolimus: Clinical, Pharmacokinetic, and Pharmacodynamic Outcomes

K. Budde, W. Arns, B. Krämer, 2007, Transplantation.

Single-center experience with the "Old for Old" program for renal transplantation.

D. Stippel, A. Hölscher, W. Arns, 2001, Transplantation proceedings.

Renal, efficacy and safety outcomes following late conversion of kidney transplant patients from calcineurin inhibitor therapy to everolimus: the randomized APOLLO study.

P. Reinke, K. Budde, C. Sommerer, 2015, Clinical nephrology.

Five‐Year Outcomes in Kidney Transplant Patients Converted From Cyclosporine to Everolimus: The Randomized ZEUS Study

F. Lehner, F. Lehner, P. Reinke, 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Renal function to 5 years after late conversion of kidney transplant patients to everolimus: a randomized trial

P. Reinke, K. Budde, C. Sommerer, 2015, Journal of Nephrology.

Patient-Reported Gastrointestinal Symptom Burden and Health-Related Quality of Life following Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium

S. Mulgaonkar, W. Arns, R. Walker, 2006, Transplantation.

Determination of unacceptable HLA antigen mismatches in kidney transplant recipients: recommendations of the German Society for Immunogenetics.

W. Arns, R. Blasczyk, F. Heinemann, 2015, Tissue antigens.

Reduction of gastrointestinal complications in renal graft recipients after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium.

P. Reinke, K. Budde, W. Arns, 2011, Transplantation proceedings.

Efficacy and safety of conversion from cyclosporine to everolimus in living‐donor kidney transplant recipients: an analysis from the ZEUS study

F. Lehner, P. Reinke, K. Budde, 2014, Transplant international : official journal of the European Society for Organ Transplantation.

Everolimus in de novo kidney transplant recipients participating in the Eurotransplant senior program: Results of a prospective randomized multicenter study (SENATOR)

F. Lehner, K. Budde, C. Sommerer, 2019, PloS one.

Everolimus immunosuppression in kidney transplantation: What is the optimal strategy?

C. Sommerer, W. Arns, O. Witzke, 2016, Transplantation reviews.

Safety and Efficacy of Intensified Versus Standard Dosing Regimens of Enteric-Coated Mycophenolate Sodium in De Novo Renal Transplant Patients

K. Budde, C. Sommerer, W. Arns, 2011, Transplantation.

Pharmacokinetics Of Erl080a: A New Enteric Coated Formulation Of Mycophenolic Acid-sodium

W. Arns, R. Schmouder, D. Russell, 1999 .

Sirolimus in renal transplantation.

A. Mehrabi, W. Arns, M. Zeier, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

A. Hartmann, N. Jamieson, W. Arns, 2009, Transplantation proceedings.

Feasibility and Potential of Transcriptomic Analysis Using the NanoString nCounter Technology to Aid the Classification of Rejection in Kidney Transplant Biopsies

W. Arns, D. Hesselink, J. Becker, 2022, Transplantation.

Should kidney allografts from old donors be allocated only to old recipients?

B. Tönshoff, L. Rostaing, O. Viklicky, 2020, Transplant international : official journal of the European Society for Organ Transplantation.

Immunosuppression in renal transplantation: some aspects for the modern era.

S. Chadban, K. Budde, W. Arns, 2008, Transplantation reviews.

Repeated kidney re‐transplantation—the Eurotransplant experience: a retrospective multicenter outcome analysis

K. Lopau, A. Rahmel, Katharina Selig, 2020, Transplant international : official journal of the European Society for Organ Transplantation.

High-urgency kidney transplantation in the Eurotransplant Kidney Allocation System: success or waste of organs? The Eurotransplant 15-year all-centre survey.

F. Lehner, H. Friess, K. Lopau, 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Efficacy and Safety of Three Different Treatment Regimens in de Novo Renal Transplant Patients: Results of the HERAKLES Trial: 1722

F. Lehner, K. Budde, C. Sommerer, 2012 .

Conversion From Cyclosporine to Everolimus at 4.5 Months Posttransplant: 3‐Year Results From the Randomized ZEUS Study

F. Lehner, F. Lehner, P. Reinke, 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial

Thomas Becker, Klemens Budde, Petra Reinke, 2011, The Lancet.

Cost-effectiveness of immunosuppressive regimens in renal transplant recipients in Germany: a model approach

W. Arns, J. Jürgensen, Wolfgang Arns, 2010, The European Journal of Health Economics.

Preemptive treatment of Cytomegalovirus infection in kidney transplant recipients with letermovir: results of a Phase 2a study

Klemens Budde, Manfred Stangl, Anja Mühlfeld, 2014, Transplant international : official journal of the European Society for Organ Transplantation.

Noninfectious gastrointestinal (GI) complications of mycophenolic acid therapy: a consequence of local GI toxicity?

W. Arns, 2007, Transplantation proceedings.

Cyclosporine C2 levels in de novo renal allograft recipients: a German multicenter prospective observational study.

D. Abendroth, W. Arns, H. Neumayer, 2005, Transplantation proceedings.

Kidney transplantation in a patient with congenital vena cava and right vena iliaca communis hypoplasia

W. Arns, A. Paul, F. Saner, 2010, Transplant international : official journal of the European Society for Organ Transplantation.

Five‐year outcomes in kidney transplant patients randomized to everolimus with cyclosporine withdrawal or low‐exposure cyclosporine versus standard therapy

F. Lehner, P. Reinke, A. Mehrabi, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Renal Function and Patient-Reported Outcomes in Stable Kidney Transplant Patients Following Conversion From Twice-Daily Immediate-Release Tacrolimus to Once-Daily Prolonged-Release Tacrolimus: A 12-Month Observational Study in Routine Clinical Practice in Germany (ADAGIO).

B. Banas, W. Arns, M. Schiffer, 2021, Transplantation proceedings.

Plasma Concentrations of Mycophenolic Acid Acyl Glucuronide Are Not Associated with Diarrhea in Renal Transplant Recipients

J. D. de Fijter, V. Armstrong, K. Budde, 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Improved Rejection Prophylaxis With an Initially Intensified Dosing Regimen of Enteric-Coated Mycophenolate Sodium in De Novo Renal Transplant Recipients

K. Budde, W. Arns, R. Walker, 2011, Transplantation.

Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study

F. Lehner, P. Reinke, K. Budde, 2018, BMC Nephrology.

Assessment of glomerular filtration rate after multiple administration of a new oral formulation of cyclosporine in clinically stable renal transplant patients.

J. Kovarik, W. Arns, E. Mueller, 1995, Transplantation proceedings.

RENAL FUNCTION, EFFICACY AND SAFETY OF EVEROLIMUS (RAD) / ENTERIC-COATED MYCOPHENOLATE SODIUM (EC-MPS) THERAPY AFTER CALCINEURIN INHIBITOR (CNI) WITHDRAWAL IN DE NOVO RENAL TRANSPLANT PATIENTS: FINAL OUTCOMES OF THE ZEUS STUDY: 264

P. Reinke, K. Budde, C. Sommerer, 2008 .

Everolimus with cyclosporine withdrawal or low-exposure cyclosporine in kidney transplantation from Month 3: a multicentre, randomized trial

F. Lehner, P. Reinke, K. Budde, 2017, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Sirolimus in renal transplant recipients with malignancies in Germany

N. Heyne, K. Budde, F. Eitner, 2020, Clinical kidney journal.

Proteinuria and sirolimus after renal transplantation: a retrospective analysis from a large German multicenter database

N. Heyne, K. Budde, F. Eitner, 2014, Clinical transplantation.

Sotrastaurin, a Novel Small Molecule Inhibiting Protein‐Kinase C: Randomized Phase II Study in Renal Transplant Recipients

F. Vincenti, K. Abrams, S. Mulgaonkar, 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Renal Transplant Patients at High Risk of Acute Rejection Benefit From Adequate Exposure to Mycophenolic Acid

J. D. de Fijter, K. Budde, L. Rostaing, 2010, Transplantation.

Pharmacokinetics and Clinical Outcomes of Generic Tacrolimus (Hexal) Versus Branded Tacrolimus in De Novo Kidney Transplant Patients: A Multicenter, Randomized Trial

K. Budde, W. Arns, T. Klein, 2017, Transplantation.

Pharmacokinetics and pharmacodynamics of intensified versus standard dosing of mycophenolate sodium in renal transplant patients.

K. Budde, C. Sommerer, W. Arns, 2010, Clinical journal of the American Society of Nephrology : CJASN.

A randomized trial of intensified vs. standard dosing for enteric-coated mycophenolate sodium in de novo kidney transplant recipients: results at 1 year.

K. Budde, S. Domhan, C. Sommerer, 2013, Clinical nephrology.

Determinants of Successful Use of Sirolimus in Renal Transplant Patients.

N. Heyne, K. Budde, F. Eitner, 2020, Transplantation proceedings.

Acute effect of cyclosporin on renal function following the initial changeover to a microemulsion formulation in stable kidney transplant patients

J. Kovarik, W. Arns, E. Mueller, 1995, Transplant international : official journal of the European Society for Organ Transplantation.